We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0HOH market cap is 396.34B. The company's latest EPS is USD -1.9382 and P/E is -2.10.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 44.67M | 257.2M | 31.31M | 3.6M | 29.5M |
| Operating Income | -814.83M | -623.05M | -563.26M | -389.09M | -337.19M |
| Net Income | -789.61M | -618.7M | -819.38M | -266.58M | -211.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.73B | 1.78B | 593.8M | 554.9M | 619.16M |
| Total Liabilities | 442.43M | 426.2M | 219.52M | 358.56M | 424.62M |
| Total Equity | 1.28B | 1.36B | 374.28M | 196.34M | 194.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -564.38M | -470.35M | -635.64M | -352.95M | -235.05M |
| Investing | 507.81M | -84.35M | 562.56M | 250.45M | 154.95M |
| Financing | 21.19M | 546.72M | -93.95M | 54.25M | 196.25M |
| Market Cap | 396.34B |
| Price to Earnings Ratio | -2.10 |
| Price to Sales Ratio | 15.09 |
| Price to Cash Ratio | 2.01 |
| Price to Book Ratio | 2.29 |
| Dividend Yield | - |
| Shares Outstanding | 109.34M |
| Average Volume (1 week) | 1.31k |
| Average Volume (1 Month) | 504 |
| 52 Week Change | 0.00% |
| 52 Week High | 3,625.00 |
| 52 Week Low | 3,625.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bluebird Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.bluebirdbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
